No CrossRef data available.
Article contents
EPA-1776 - Alexithymia, Depression, Anxiety Levels and Quality of Life in Patients With Rheumatoid Arthritis
Published online by Cambridge University Press: 15 April 2020
Abstract
The aim of the study was level of anxiety, depression and alexithymia in patients with rheumatoid arthritis (RA).
Alexithymia is defined as the difficulty in verbal expression of feelings. Alexithymia is more common seen in patients with chronic and temporary health problems.
One hundred forty eight patients with rheumatoid arthritis and a hundred healthy subject were included into the study. The level of alexithymia was assessed with Toronto Alexithymia Scale- 20 (TAS-20). Depression and anxiety disorders severity and quality of life (QoL) were assessed Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), World Health Organization Quality of Life Assessment- Brief (WHOQoL-BREF), respectively.
TAS-20 scores in patients group was higher than control group. The patients with rheumatoid arthritis had significantly poorer scores in all domains of WHOQoL-BREF (p<0.001). BDI and BAI scores were greater than control group. There was no significant difference between patients with or without alexithymia in terms of sociodemographic features, treatment and scales scores.
The results of this study suggest that alexithymia is more common in patients with RA. Treatment of alexithymia may improve QoL, depressive and anxiety symptoms.
- Type
- P06 - Consultation Liaison Psychiatry and Psychosomatics
- Information
- Copyright
- Copyright © European Psychiatric Association 2014
Comments
No Comments have been published for this article.